Rhinorus, 0.1% spray 20 ml

Vasoconstrictor for local use in ENT practice.

Xylometazoline (imidazoline derivative) is an alpha-adrenomimetic, causes narrowing of blood vessels of nasal mucosa, eliminating its edema and hyperemia, restores nasal passageway patency, facilitates nasal breathing and improves nasal discharge in rhinitis (runny nose) of different origin.

The action of the drug starts within a few minutes after application and lasts up to 10 hours.

Indications

acute rhinitis (including against the background of acute respiratory diseases and allergic rhinitis);
sinusitis;
eustachitis;
otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
to facilitate rhinoscopy;
preparing patients for diagnostic manipulations in the nasal passages.

Pharmacological effect

Vasoconstrictor drug for local use in ENT practice.

Xylometazoline (imidazoline derivative) is an alpha-adrenergic agonist, causes a constriction of the blood vessels of the nasal mucosa, eliminating its swelling and hyperemia, restores the patency of the nasal passages, facilitates nasal breathing and improves the discharge of nasal discharge during rhinitis (runny nose) of various origins.

The effect of the drug begins a few minutes after its use and lasts up to 10 hours.

Special instructions

Should not be used for a long time, for example for chronic rhinitis.

In dosages exceeding recommended doses, may affect the ability to drive a vehicle or operate equipment.

Active ingredient

Xylometazoline

Composition

1 ml contains:

Active ingredient:

xylometazoline hydrochloride 1 mg;

Excipients:

benzalkonium chloride,

sodium chloride,

disodium edetate,

sodium dihydrogen phosphate dihydrate,

sodium hydrogen phosphate dodecahydrate,

eucalyptus oil,

water d/i.

Contraindications

arterial hypertension;
tachycardia;
severe atherosclerosis;
glaucoma;
atrophic rhinitis;
hyperthyroidism;
surgical interventions on the meninges (history);
pregnancy (for nasal drops);
children under 2 years of age;
children under 6 years of age (for nasal drops 0.1% and nasal spray 0.1%);
hypersensitivity to the components of the drug (including eucalyptus oil).

Do not use during therapy with MAO inhibitors and tricyclic antidepressants, as well as with other drugs that increase blood pressure.

The drug should be prescribed with caution for diabetes mellitus, coronary artery disease, angina pectoris of functional class III-IV, prostatic hyperplasia, and during lactation.

Side Effects

Local reactions: with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions: vomiting, headache, palpitations, increased blood pressure, insomnia, blurred vision, depression (with long-term use of high doses).

Interaction

It is possible to enhance the systemic effect with simultaneous use of MAO inhibitors and tricyclic antidepressants.

Overdose

Symptoms: increased side effects.

Treatment: symptomatic under medical supervision.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

2 years

Manufacturer

Sintez, Russia